Biotech

All Articles

Lilly- supported weight management biotech reports IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has submitted to...

Aelis' cannabis use medicine fails phase 2b, driving Indivior to reassess $100M choice

.Aelis Farma's hopes of securing a quick, favorable decision on a $one hundred million option paymen...

ProKidney standstills phase 3 trial certainly not required for cell therapy confirmation

.ProKidney has stopped among a pair of phase 3 tests for its cell therapy for kidney health conditio...

Vaxcyte surges on 'stunning' 31-valent PCV succeed against Pfizer

.Vaxcyte revealed what professionals named "stunning" phase 1/2 records for its 31-valent pneumococc...

Recursion's human brain condition test shows little proof of efficacy

.Recursion has actually stumbled via an early examination of its own tech-enabled strategy to medica...

Acepodia, Pfizer click on all together for chemistry-based tissue treatment

.Phone it a situation of really good chemical make up: Acepodia, a biotech based upon Nobel Champion...

Praxis epilepsy medicine lowers confiscations in phase 2 trial

.Praxis Accuracy Medicines has racked up one more midphase succeed in epilepsy this year, along with...

Three directors surrender as Dyne articles mixed data for DMD prospect

.After getting away a scientific grip numerous years back, Dyne Therapy has revealed new phase 1/2 d...

Arrowhead fires off stage 3 records in unusual metabolic ailment in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has shown its give before a potential face-off with Ionis, posting stage ...

Pfizer, Valneva reveal lyme condition try successful for second enhancer

.Pfizer as well as Valneva may have regarding pair of even more years to wait before they create the...